kabutan

COSMOS Pharma, 0.1％ Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 5 Yen, This Fiscal Year to Increase Dividend by 5 Yen

Fri Jul 11, 2025 3:30 pm JST Earnings

3349 COSMOS Pharmaceutical Corporation 【J-GAAP】

Earnings Report

COSMOS Pharmaceutical Corporation <3349> [TSE Prime] announced its financial results after the market closed on July 11th (15:30). The consolidated ordinary profit for the fiscal year ended May 2025 increased by 25.8% from the previous period to 43.1 billion yen, exceeding the previous forecast of 34.4 billion yen. For the fiscal year ending May 2026, the consolidated ordinary profit is nearly flat with a slight increase of 0.1% to 43.2 billion yen, marking the second consecutive term of record-high profits. This will be the 25th consecutive term of revenue and the fourth consecutive term of profit growth.

At the same time, the company increased the annual dividend for the previous term from 65 yen to 70 yen (compared to 120 yen before the 2-for-1 forward stock split in the previous term), and has decided to increase the dividend this fiscal year to 75 yen, an increase of 5 yen from the previous fiscal year.

In the most recent three-month period, from March to May (4Q), the consolidated ordinary profit grew 12.0% from the same period last year, reaching 9.38 billion yen. The operating profit margin remained almost flat, changing from 3.1% in the same period last year to 3.4%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2023 827,697 30,128 33,086 23,797 300.5 50 Jul 10, 2023 J-GAAP
May, 2024 964,989 31,501 34,299 24,454 308.6 60 Jul 12, 2024 J-GAAP
May, 2025 1,011,390 40,404 43,160 30,978 390.9 70 Jul 11, 2025 J-GAAP
YoY +4.8% +28.3% +25.8% +26.7% +26.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2025 Guidance 1,037,000 31,600 34,400 24,500 309.1 65 Jul 12, 2024 J-GAAP
May, 2025 Results 1,011,390 40,404 43,160 30,978 390.9 70 Jul 11, 2025 J-GAAP
Revision Rate -2.5% +27.9% +25.5% +26.4% +26.4%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun - Nov, 2024 505,936 20,344 21,777 14,428 182.1 32.50 Jan 10, 2025 J-GAAP
Jun - Nov, 2025 Guidance 525,000 20,420 21,780 14,650 184.8 37.50 Jul 11, 2025 J-GAAP
YoY +3.8% +0.4% +0.0% +1.5% +1.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2024 964,989 31,501 34,299 24,454 308.6 60 Jul 12, 2024 J-GAAP
May, 2025 1,011,390 40,404 43,160 30,978 390.9 70 Jul 11, 2025 J-GAAP
May, 2026 Guidance 1,057,000 40,500 43,200 31,000 391.1 75 Jul 11, 2025 J-GAAP
YoY +4.5% +0.2% +0.1% +0.1% +0.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Mar - May, 2024 249,678 7,763 8,385 7,097 89.6 3.1 Jul 12, 2024 J-GAAP
Jun - Aug, 2024 261,841 11,580 12,293 8,143 102.7 4.4 Oct 11, 2024 J-GAAP
Sep - Nov, 2024 244,095 8,764 9,484 6,285 79.3 3.6 Jan 10, 2025 J-GAAP
Dec - Feb, 2024 246,332 11,283 11,994 7,915 99.9 4.6 Apr 14, 2025 J-GAAP
Mar - May, 2025 259,122 8,777 9,389 8,635 109.0 3.4 Jul 11, 2025 J-GAAP
YoY +3.8% +13.1% +12.0% +21.7% +21.6%

Related Articles